BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 26472030)

  • 1. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
    Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
    Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells.
    Khaw AK; Hande MP; Kalthur G; Hande MP
    J Cell Biochem; 2013 Jun; 114(6):1257-70. PubMed ID: 23192708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-quadruplex antibody attenuates human gastric cancer cell proliferation and promotes apoptosis through hTERT/telomerase pathway.
    Zhang YQ; Pei JH; Shi SS; Zheng J; Wang JM; Guo XS; Cui GY; Wang XY; Zhang HP; Hu WQ
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2614-2623. PubMed ID: 29771410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells.
    Shalem-Cohavi N; Beery E; Nordenberg J; Rozovski U; Raanani P; Lahav M; Uziel O
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive inhibition of hTERT expression by a ribozyme induces rapid apoptosis of cancer cells through a telomere length-independent pathway.
    Hao ZM; Luo JY; Cheng J; Li L; He D; Wang QY; Yang GX
    Cancer Biol Ther; 2005 Oct; 4(10):1098-103. PubMed ID: 16205109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells.
    Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
    Cancer Lett; 2009 Dec; 286(2):172-9. PubMed ID: 19560862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
    Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of hTERT expression by low-dose cisplatin contributes to chemotherapy resistance in human hepatocellular cancer cells.
    Guo XL; Ma NN; Zhou FG; Zhang L; Bu XX; Sun K; Song JR; Li R; Zhang BH; Wu MC; Wei LX
    Oncol Rep; 2009 Sep; 22(3):549-56. PubMed ID: 19639202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
    Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
    Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.
    Patel PL; Suram A; Mirani N; Bischof O; Herbig U
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5024-33. PubMed ID: 27503890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues.
    Li W; Li L; Liu Z; Liu C; Liu Z; Strååt K; Björkholm M; Jia J; Xu D
    Cancer Lett; 2008 Feb; 260(1-2):28-36. PubMed ID: 18037230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-apoptotic and anti-proliferative effects of 3,3'-diindolylmethane in nasopharyngeal carcinoma cells via downregulation of telomerase activity.
    Li F; Xu Y; Chen C; Chen SM; Xiao BK; Tao ZZ
    Mol Med Rep; 2015 Sep; 12(3):3815-3820. PubMed ID: 26004560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
    Vahidi S; Norollahi SE; Agah S; Samadani AA
    J Gastrointest Cancer; 2020 Sep; 51(3):788-799. PubMed ID: 32617831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere dysfunction induced by chemotherapeutic agents and radiation in normal human cells.
    Li P; Hou M; Lou F; Björkholm M; Xu D
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1531-40. PubMed ID: 22728163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer.
    Choi BJ; Yoon JH; Kim O; Choi WS; Nam SW; Lee JY; Park WS
    World J Gastroenterol; 2015 Aug; 21(31):9328-36. PubMed ID: 26309358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells.
    Tauchi T; Nakajima A; Sashida G; Shimamoto T; Ohyashiki JH; Abe K; Yamamoto K; Ohyashiki K
    Clin Cancer Res; 2002 Nov; 8(11):3341-7. PubMed ID: 12429620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.